Similar articles

• Myoclonic attacks induced by L-dopa and bromocryptin in Parkinson patients: a sleep EEG study.

  Vardi J, Glaubman H, Rabey JM, Streifler M. Vardi J, et al. J Neurol. 1978 Apr 14;218(1):35-42. doi: 10.1007/BF00314716. J Neurol. 1978. PMID: 77316
• Bromocriptine in the treatment of parkinsonism.

  Parkes JD. Parkes JD. Drugs. 1979 May;17(5):365-82. doi: 10.2165/00003495-197917050-00006. Drugs. 1979. PMID: 37066 Review.
• L-dopa induced "serotonin syndrome" in a parkinsonian patient on bromocriptine.

  Sandyk R. Sandyk R. J Clin Psychopharmacol. 1986 Jun;6(3):194-5. doi: 10.1097/00004714-198606000-00022. J Clin Psychopharmacol. 1986. PMID: 3711372 No abstract available.
• Psychiatric effects of bromocriptine and lergotrile in Parkinsonian patients.

  Serby M, Angrist B, Lieberman A. Serby M, et al. Adv Biochem Psychopharmacol. 1980;23:287-92. Adv Biochem Psychopharmacol. 1980. PMID: 6104908 No abstract available.
• Bromocriptine in Parkinson disease.

  Lieberman AN, Goldstein M. Lieberman AN, et al. Pharmacol Rev. 1985 Jun;37(2):217-27. Pharmacol Rev. 1985. PMID: 3901046 Review.